In this study, we show that the presence of PD-1 blocking antibodies during in vitro stimulation increases activation of tumor-infiltrating MAIT cells in a subset of colon cancer patients, indicating that checkpoint blockade may act on unconventional T cells from cancer patients. Here, PDCD1 is linked to cancer.